Clinical Pharmacology of Psychotropic Drugs

Psychotropic drugs form the cornerstone of pharmacotherapy for mental disorders including depression, anxiety disorders, psychoses, bipolar affective disorder and attention-deficit/hyperactivity disorder (ADHD). This review summarizes mechanisms of action, pharmacokinetics, therapeutic uses, adverse effects, drug interactions, and clinical monitoring requirements for major classes of psychotropic agents. Particular attention is paid to rational prescribing principles, special population considerations, and emerging trends in drug development. Understanding pharmacological properties and safety profiles is essential for optimizing clinical outcomes and minimizing harm in patients receiving psychotropic treatment.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-18
DOI
https://doi.org/10.5281/zenodo.17384536
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Pharmacology of Psychotropic Drugs

Zenodo (CERN European Organization for Nuclear Research)
Schizophrenia research and treatment
article

Clinical Pharmacology of Psychotropic Drugs

article en

Abstract

Psychotropic drugs form the cornerstone of pharmacotherapy for mental disorders including depression, anxiety disorders, psychoses, bipolar affective disorder and attention-deficit/hyperactivity disorder (ADHD). This review summarizes mechanisms of action, pharmacokinetics, therapeutic uses, adverse effects, drug interactions, and clinical monitoring requirements for major classes of psychotropic agents. Particular attention is paid to rational prescribing principles, special population considerations, and emerging trends in drug development. Understanding pharmacological properties and safety profiles is essential for optimizing clinical outcomes and minimizing harm in patients receiving psychotropic treatment.

Zenodo (CERN European Organization for Nuclear Research)
Osh State University (KG)
Good health and well-being
Openalex Percentile: Top 44%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.